half area white ps polystyrol flat bottom tc plates (Greiner Bio)
Greiner Bio is a verified supplier 
94
Structured Review
Greiner Bio
half area white ps polystyrol flat bottom tc plates
Half Area White Ps Polystyrol Flat Bottom Tc Plates, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 94/100, based on 233 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/half+area+white+ps+polystyrol+flat+bottom+tc+plates/Cell+Culture+Microplate+96+Well+Ps+Half+Area/pmc12257526__jm5c00552_si_001-130-28-37
Average 94 stars, based on 233 article reviews
Half Area White Ps Polystyrol Flat Bottom Tc Plates, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 94/100, based on 233 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/half+area+white+ps+polystyrol+flat+bottom+tc+plates/Cell+Culture+Microplate+96+Well+Ps+Half+Area/pmc12257526__jm5c00552_si_001-130-28-37
Average 94 stars, based on 233 article reviews
half area white ps polystyrol flat bottom tc plates - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
Expressing:Article Title: Development of a Potent and Selective G2A (GPR132) Agonist. Article Snippet: G protein-coupled receptor G2A was postulated to be a promising target for the development of new therapeutics in neuropathic pain, acute myeloid leukemia, and inflammation.. However, there is still a lack of potent, selective, and drug-like G2A agonists to be used as a chemical tool or as the starting matter for the development of drugs.. In this work, we present the discovery and structure−activity relationship elucidation of a new potent and selective G2A agonist scaffold. Concentration Assay:Article Title: Development of a Potent and Selective G2A (GPR132) Agonist. Article Snippet: G protein-coupled receptor G2A was postulated to be a promising target for the development of new therapeutics in neuropathic pain, acute myeloid leukemia, and inflammation.. However, there is still a lack of potent, selective, and drug-like G2A agonists to be used as a chemical tool or as the starting matter for the development of drugs.. In this work, we present the discovery and structure−activity relationship elucidation of a new potent and selective G2A agonist scaffold. |